
A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …

Merck Serono and Medicines for Malaria Venture (MMV) have signed an agreement which will see them advance the development of …

Resistance to a group of drugs that possess the most rapid action against malaria – artemisinin, aka Qinghaosu – is …

A cheap iPhone app developed last year has demonstrated high-level effectiveness towards identifying bogus antimalarial treatments. A recent study published …

Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …

GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …

GlaxoSmithKline says it is just two years away from marketing the world’s first malaria vaccine RTS,S. This follows results from …


Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …
Eurartesim, the first artemisinin combination therapy (ACT) approved in Europe to treat uncomplicated malaria, is being prepared for launch in …
Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …

Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …
Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …